Development of Lansoprazole Sustained-Release Microparticles Using Solvent Evaporation Method

碩士 === 國立臺灣大學 === 藥學研究所 === 96 === Lansoprazole is a proton pump inhibitor which selectively inhibits H+/K+-ATPase. It is usually used for gastric ulcer diseases. However, due to its short half life in plasma, lansoprazole cannot control nocturnal acid breakthrough. This study was aimed to improve t...

Full description

Bibliographic Details
Main Authors: Wei-Zhe Sun, 孫偉哲
Other Authors: 林文貞
Format: Others
Language:zh-TW
Published: 2008
Online Access:http://ndltd.ncl.edu.tw/handle/89328606200515275042